Making the switch from alteplase to tenecteplase for stroke thrombolysis can be done successfully when the appropriate preparations are taken, and it may improve patient outcomes, the experience of a ...

Switching from alteplase to tenecteplase as the thrombolytic used routinely for acute ischemic stroke is having multiple benefits for one US hospital system. Tenecteplase was developed as a more ...

The thrombolytic tenecteplase may have a role in reestablishing blood flow in patients with large-vessel acute ischemic stroke up to 24 hours after stroke onset selected by perfusion imaging, a new ...

Administering tenecteplase (TNK) up to 24 hours after an acute ischemic stroke caused by a large-vessel occlusion appears to be a viable option among patients selected with advanced imaging, the phase ...

Tenecteplase, a genetically modified tissue plasminogen activator derived from alteplase, has recently been shown to be as effective and safe as alteplase for the treatment of acute ischemic stroke.

Intravenous tenecteplase (TNKase) before endovascular thrombectomy improved outcomes for acute ischemic stroke patients who presented within 4.5 hours after onset in a randomized trial from China. The ...

Tenecteplase (TNKase) appeared feasible for thrombolysis in acute ischemic stroke in patients presenting up to 24 hours after symptom onset, a phase II trial suggested. The typical 0.25 mg/kg dose of ...

Japanese trial compared lytics for bridging before endovascular thrombectomy ...

Thrombolytic therapy is generally considered the standard of care for eligible patients within 4.5 hours after the onset of acute ischemic stroke. Thrombolytic agents, such as alteplase and ...

The approval marks the first new stroke treatment authorized in nearly 27 years, offering an additional option for managing acute ischemic stroke in Canada. MISSISSAUGA, ON, Dec. 17, 2025 /CNW/ - ...

Please provide your email address to receive an email when new articles are posted on . Among patients with acute ischemic stroke who were selected for thrombectomy, treatment with tenecteplase, ...